主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Zhang Rongjin Wang Shumin Cui Ligang
英文单位:Department of Ultrasound Diagnosis Peking University Third Hospital Beijing 100191 China
英文关键词:Renalcellcarcinoma;Venoustumorthrombus;TNMstaging
肾细胞癌是泌尿系统常见的恶性肿瘤,局部进展期肾细胞癌常伴有静脉癌栓,部分患者的癌栓可延伸至下腔静脉。2017年美国癌症联合委员会提出的TNM分期将T3期肾细胞癌定义为静脉系统癌栓、肾窦和/或肾周脂肪浸润,关于其对预后的评估价值存在较多争议。充分合理地利用多种影像学检查及参数有助于在术前对不同局限性侵犯肾细胞癌患者进行预后评估。本文总结了T3期肾细胞癌的预后相关研究,以及多种影像学检查及参数对伴静脉癌栓患者预后评估价值的研究进展。
Renal cell carcinoma (RCC) is a common malignant tumor of the urinary system. Locally advanced RCC is often accompanied by venous cancer thrombus, which can extend to the inferior vena cava in some patients. TNM staging system, proposed by American Joint Committeeon Cancer in 2017, classifies stage T3 RCC as venous system tumor thrombus, renal sinus and/or perirenal fat invasion, and there are many controversies regarding its prognostic value. Reasonable use of multiple imaging examinations and parameters is helpful for preoperatively prognostic evaluation in patients with different localized RCC. This article reviews the research progress in related prognostic research of stage T3 RCC and the value of various imaging examinations and parameters in evaluating the prognosis of patients with venous tumor thrombus.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。